Guideline for Differentiating Depression‑Related Cognitive Impairment from Early Neurodegenerative Disease

1. Epidemiology & Clinical Context

Dementia affects approximately 5% of persons aged 71-79 years, 24% of those aged 80-89 years, and 37% of those older than 90 years, according to the American Geriatrics Society 7
Alzheimer disease accounts for 60-80% of all dementia cases, followed by vascular dementia (10-20%), dementia with Lewy bodies (5-10%), and frontotemporal dementia (12-25%), as reported by the American College of Physicians 7
More than half of cognitively unimpaired individuals who subsequently develop dementia had depression or irritability symptoms prior to cognitive impairment, making the distinction between primary depression and early dementia challenging, as noted by the Alzheimer's Association 8, 9
Anxiety disorders occur 2-3 times more frequently in older adults than expected population prevalence, according to the American Psychiatric Association 10
Behavioral and psychological symptoms of dementia (BPSD) affect 78% of individuals with dementia, representing a major clinical challenge, as reported by the American Geriatrics Society 11, 12

Pharmacological treatment with SSRIs (such as sertraline) and psychological interventions are effective in reducing depressive symptoms in older adults, as recommended by the American Geriatrics Society 13
FDA-approved pharmacologic treatments for dementia include acetylcholinesterase inhibitors (AChEIs) such as donepezil and memantine, according to the American College of Physicians 7
Nonpharmacologic interventions for dementia include cognitive training, exercise, educational interventions, and multidisciplinary care interventions, as reported by the American College of Physicians 7
After eliminating medical causes, psychotherapy with or without anxiolytics or antidepressants is recommended for anxiety treatment, according to the National Comprehensive Cancer Network 14

Clinicians should assess older adults for cognitive impairment using standardized screening instruments during initial evaluation and with any significant decline in clinical status, as recommended by the American Geriatrics Society 13
A majority of individuals older than age 80 with cognitive impairment harbor more than one type of brain pathological change, resulting in mixed etiology dementia, as noted by the Alzheimer's Association 8, 9
Polypharmacy is common in dementia and can contribute to psychiatric symptoms, with anticholinergics, benzodiazepines, and antipsychotics potentially worsening symptoms, according to the American Geriatrics Society 15
SSRIs and SNRIs used to treat depression may cause or exacerbate insomnia, as reported by the American Geriatrics Society 16

Avoid misinterpreting new-onset depression as purely psychiatric when it may represent early dementia, as noted by the Alzheimer's Association 8, 9
Recognize that unrecognized pain is common in dementia and can manifest as increased behavioral symptoms or apparent psychiatric deterioration, according to the American Geriatrics Society 15
Be aware that sleep disturbances affect a significant portion of adults over age 65 and are associated with depression, cognitive decline, and increased fall risk, as reported by the American Geriatrics Society 16